PWMA
MRNA icon

Pension & Wealth Management Advisors’s Moderna MRNA Stock Holding History

Pension & Wealth Management Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-200
Closed -$24.3K – 281
2023
Q2 		$24.3K Hold
200
– – 0.02% 188
2023
Q1 		$30.7K Hold
200
– – 0.02% 182
2022
Q4 		$35.9K Buy
+200
New +$32.7K 0.03% 172

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Pension & Wealth Management Advisors's MRNA Position: Q3 2023 in Review

Pension & Wealth Management Advisors sold out of Moderna (MRNA) in Q3 2023, closing a stake of 200 shares — an estimated $24.3K sold.

Pension & Wealth Management Advisors first reported a position in MRNA in Q4 2022 and held it in 3 quarters. The position peaked at $35.9K in Q4 2022. 890 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Pension & Wealth Management Advisors reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Pension & Wealth Management Advisors sold 200 Moderna shares in Q3 2023, an estimated $24.3K.
  • Pension & Wealth Management Advisors first reported a position in Moderna in Q4 2022 and held it in 3 quarters.
  • Pension & Wealth Management Advisors's Moderna position peaked at $35.9K in Q4 2022.
  • 890 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Pension & Wealth Management Advisors's 13F filing for Q3 2023, filed 7 Aug 2026.